Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 3,083 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Guideline Clear all

Conditions: Concussion, Brain, Brain Injury Traumatic Mild
Interventions: Concussion-focused cognitive behavioral therapy, Parent skills training, Care management; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 11 Years to 18 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Body Image, Self Esteem, Weight Loss, Health Behavior, Health-Related Behavior, Health Knowledge, Attitudes, Practice
Interventions: FASTer Way Intervention, Control Group Intervention; Other
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Mitral Valve Insufficiency
Interventions: Mitral valve surgery; Procedure
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Coronary Artery Disease
Interventions: MyoVista device, Computed tomographic coronary angiography, Transthoracic Echocardiography; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Pneumonia, Severe Acute Respiratory Syndrome, Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions: Best Practice, Low Dose Radiation Therapy; Other · Radiation
Lead sponsor: Emory University; Other
Eligibility: 50 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stroke, Atherosclerosis
Interventions: High Risk - intensive coaching, High Risk - standard care, Low Risk - control; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Madison, Wisconsin • Oneida, Wisconsin

Conditions: Acute Graft Versus Host Disease, Haploidentical Hematopoietic Stem Cell Transplant
Interventions: ApoGraft; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: HTN Educational Video, Visual Echocardiogram Image Clips, Mobile Health and Remote BP monitoring, Post-Acute Care HTN Transition consultation (PACHT-c); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Adverse Drug Events, Medication Administered in Error
Interventions: Mentored medication reconciliation quality improvement; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,836 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 6
States / cities: San Francisco, California • Johns Creek, Georgia • Chicago, Illinois + 3 more

Conditions: Asthma in Children
Interventions: Asthma Care Provider Training, School Staff Asthma Education; Behavioral
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 2
States / cities: Tucson, Arizona • Denver, Colorado

Conditions: Prostate Carcinoma
Interventions: Best Practice, Discussion, Survey Administration, Virtual Reality; Other · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPS
Interventions: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect), Lifestyle Counseling - Diet & Physical-Activity Program; Procedure · Drug · Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stage III Non-small Cell Lung Cancer
Interventions: Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy, Immunotherapy; Device · Drug
Lead sponsor: Varian, a Siemens Healthineers Company; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Heart Failure, Systolic
Interventions: Biofourmis Digital Platform; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
Interventions: ALE.P02, Pembrolizumab; Drug
Lead sponsor: Alentis Therapeutics AG; Industry
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 8
States / cities: Scottsdale, Arizona • Fullerton, California • Los Angeles, California + 5 more

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma, Sarcoma, Neuroblastoma
Interventions: Food Safety Guidelines, Neutropenic Diet; Other
Lead sponsor: Indiana University; Other
Eligibility: 1 Year to 30 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 6
States / cities: San Diego, California • Indianapolis, Indiana • Brooklyn, New York + 2 more

Conditions: Cancer Survivorship, Primary Care
Interventions: KanSurvive telementoring and education, Practice facilitation for quality improvement, Obesity management toolkit, Survivorship Care Manual, Virtual scribe services; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Dermatitis, Atopic
Interventions: Educational handbook; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 30 Days to 16 Years
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ventricular Dysfunction, Left
Interventions: Revivent TC; Device
Lead sponsor: BioVentrix; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 25
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 20 more

Conditions: Chronic Kidney Disease, Hemodialysis Vascular Access
Interventions: Educational Materials, Motivational Interviewing, Usual Care, Patient Lists for Clinicians: System-Level Intervention; Behavioral · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Baltimore, Maryland • Chapel Hill, North Carolina • Philadelphia, Pennsylvania

Conditions: Intellectual Disability, Developmental Disability, Axis I Diagnosis, Mental Illness, Covid19, Coronavirus
Interventions: Generic Best Practices, Tailored Best Practices; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carcinoid Tumors
Interventions: Ramucirumab, Somatostatin Analog; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Major Depressive Disorder, Depression
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID
Interventions: Convalescent Plasma, Standard Donor Plasma; Biological
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Search by objective public record fields.

Concussion Health Improvement Program

The Effectiveness on an Application-Based Lifestyle Change Program on Health in Women

MRI as a Predictor of Outcomes in Patients Undergoing Mitral Valve Surgery

Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19

Stroke Prevention in the Wisconsin Native American Population

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Targeting of UnControlled Hypertension in Emergency Department

Multi-Center Medication Reconciliation Quality Improvement Study

An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

Digital Remote Home Monitoring for Heart Failure

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice

Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook

BioVentrix Revivent TC™ System Clinical Study

Transforming Hemodialysis-Related Vascular Access Education

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Mechanism of Action of Transcranial Magnetic Stimulation

Convalescent Plasma vs. Standard Plasma for COVID-19